Atlas FDA

VNS THERAPY SYSTEM

FDA premarket approval P970003/S174 · decided 2015-06-04

Approval details

PMA number
P970003
Supplement
S174
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
VNS THERAPY SYSTEM
Generic name
Stimulator, autonomic nerve, implanted (depression)
Applicant
LivaNova USA, Inc.
Date received
2014-11-17
Decision date
2015-06-04
Days to decision
199 days
Decision code
APPR
Product code
MUZ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08